Exosomes from prostate cancer cells further impair tumor-infiltrating CD8+ T cells by releasing IL-8, which activates PPARα in receptor cells and subsequently upregulates CPT1A expression in tumor cells, disrupting energy metabolism [134]. The gene discussed is CPT1A; the disease is neoplasm.